Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

The impact of MYC locus aberrations on the outcome of multiple myeloma (MM) patients is still a matter of debate. The aim of this study was to further investigate their influence on the survival of MM patients treated with high-dose chemotherapy. Our data suggest that the favorable prognosis factor

Bibliographic Details

Main Authors:	Weinhold, Niels (Author) , Kirn, Désirée (Author) , Seckinger, Anja (Author) , Hielscher, Thomas (Author) , Granzow, Martin (Author) , Bertsch, Uta (Author) , Egerer, Gerlinde (Author) , Salwender, Hans (Author) , Blau, Igor W. (Author) , Weisel, Katja (Author) , Hillengaß, Jens (Author) , Raab, Marc-Steffen (Author) , Hose, Dirk (Author) , Goldschmidt, Hartmut (Author) , Jauch, Anna (Author)
Format:	Article (Journal) Editorial
Language:	English
Published:	March 2016
In:	Haematologica Year: 2016, Volume: 101, Issue: 3, Pages: e116-e119
ISSN:	1592-8721
DOI:	10.3324/haematol.2015.136929
Online Access:	Verlag, Volltext: https://doi.org/10.3324/haematol.2015.136929 Verlag, Volltext: http://www.haematologica.org/content/101/3/e116
Author Notes:	Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans Salwender, Igor W. Blau, Katja Weisel, Jens Hillengass, Marc S. Raab, Dirk Hose, Hartmut Goldschmidt and Anna Jauch